QA CSV Engineer

Vor 2 Tagen

Oberwallis, Wallis, Schweiz Source Group International Vollzeit CHF 120’000 - CHF 180’000 Vertrag

Purpose

  • Provide independent quality oversight and documented challenge of OT CSV and data-integrity remediation.

Revised responsibilities

  • Review/challenge scope, risk rankings, test strategy, deviations, validation reports and CAPA evidence.
  • Verify independence from authors/executors and identify unresolved GMP risks.
  • Review DI controls and critical electronic-record lifecycle evidence with the DI specialists.
  • Prepare QA-approved inspection narratives and coach technical SMEs; escally critical deficiencies.
  • Recommend acceptance/rejection; sign as approver only if documented Lonza delegation permits (decision D05).

Must-have requirements (recruitment)

  • Substantial independent QA oversight of computerized systems in GMP (15+ years preferred; 10+ with strong oversight record flagged for D09).
  • Direct FDA inspection experience (front room or back room) on computerized system or data integrity topics.
  • Expert knowledge of 21 CFR Part 11, EU GMP Annex 11, GAMP 5 (Second Edition) and data integrity guidance (FDA, MHRA, PIC/S); QA experience on OT/automation systems, preferably DeltaV.
  • Willing and able to travel to Visp 2 days per month. Fluent English.
  • Nice-to-have: FDA 483/warning-letter remediation, biologics manufacturing, qualified GMP auditor, German.
  • CV keywords: independent QA review, FDA inspection, 483, warning letter, Part 11, Annex 11, PIC/S, MHRA DI, DeltaV, CAPA.

Critical competencies

  • Independent GMP QA CSV oversight and direct FDA inspection exposure; senior profile (15+ years preferred, D09 pending).
  • Expert OT computerized systems, DeltaV/batch/historian control risks, Part 11, Annex 11, GAMP 5 and DI guidance.
  • Ability to challenge weak risk justifications, insufficient evidence and ineffective CAPAs.

CV screening knock-out criteria (screening w/c 19-Oct-2026)

  • No direct FDA inspection exposure.
  • Execution-only CSV background without an independent QA oversight role.
  • Not available to start between 2-Nov-2026 and 1-Dec-2026.

Minimum deliverables

  • QA review log, challenge register and disposition decisions.
  • Documented review of critical validation/DI packages and inspection readiness evidence.
  • Escalation log and recommended acceptance/residual-risk statements.

We believe in equal opportunity for all and actively encourage applications from diverse backgrounds, experiences, and perspectives.